News & Research

Parkinson's News

Stay informed with the latest research, breakthroughs, and news in Parkinson's disease from trusted sources worldwide.

Latest Headlines

Parkinson's News TodayJul 31, 2026

Zelapar (selegiline hydrochloride) for Parkinson’s disease

Zelapar (selegiline hydrochloride) is an oral add-on therapy used to help control off episodes and ease motor fluctuations in Parkinson's disease patients who already are on levodopa and carbidopa tre...

Parkinson's News TodayJul 31, 2026

Guest Voice: Simple bedroom fixes help ensure my husband’s safe sleep

One evening, as I was lying in bed reading a novel, I watched my husband, Dave, out of the corner of my eye. Once again, he was having trouble getting out of bed. He couldn’t pull himself up far enoug...

Parkinson's News

Latest Headlines

Zelapar (selegiline hydrochloride) for Parkinson’s disease

Guest Voice: Simple bedroom fixes help ensure my husband’s safe sleep

More Stories

Study shows Parkinson’s affects brain circuits in different ways

Neupro (rotigotine transdermal system) for Parkinson’s disease

Blood marker may help detect cognitive decline in Parkinson’s: Study

Ropinirole hydrochloride for Parkinson’s disease

Ongentys (opicapone) for Parkinson’s disease

Comtan (entacapone) for Parkinson’s disease

‘Going fishing’ was the response to a discouraging doctor’s appointment

Parkinson’s forces me to consider what I am passing along

Leucine-rich repeat kinase 2 impairs the release sites of Parkinson’s disease vulnerable dopamine axons

A multimodal mobile dataset for Parkinson’s disease symptom assessment

Spatial multi-omics identifies early synaptic pruning and context-specific dopaminergic vulnerability in synucleinopathies

Red blood cell-derived parameters as a potential tool in the differential diagnosis of parkinsonian syndromes

Brain-first and body-first subtypes of Lewy body disease

Development of an RNA aptamer as a therapeutic agent for synucleinopathies

Astrocytic lipid dysregulation as an early driver of neurodegeneration

Monitoring nocturnal movement and sleep in Parkinson’s disease: a systematic review of movement sensors

Human embryonic stem cell-derived dopaminergic cells for Parkinson’s disease: a phase 1/2 open-label trial

The clinical manifestation and neural correlates of cognitive-motor interference in Parkinson’s disease

Our Sources